Workflow #656
✓ CompletedType: Benzinga Article
Started: December 02, 2025 at 12:35:00 PM
Completed: December 02, 2025 at 12:35:23 PM
Completed in 23s
Triggered by: ingestion
Job Pipeline
clean_raw_article
✓ completed→
clean_markdown_article
✓ completed→
analyze_article
✓ completed→
link_article_to_stories
⊘ skipped→
analyze_sentiment
✓ completedclean_raw_article
✓ CompletedPending
clean_markdown_article
✓ CompletedPending
analyze_article
✓ CompletedPending
link_article_to_stories
⊘ SkippedSkipped
analyze_sentiment
✓ CompletedPending
Workflow Context
title:The FDA Has Accepted Astrazeneca's New Drug Application For Baxdrostat For Patients With Hard-to-control Hypertension As An Add-on To Other Antihypertensive Medicines, The Prescription Drug User Fee Act Date Is Anticipated During Q2 Of 2026 Following Use Of A Priority Review Voucher
source:Benzinga
content:
article_id:1110 →
content_type:article